New research shows that inherited melanomas are more common than previously realized. Specifically, in a study of almost 700,000 people, about 1 in 100-200 individuals had a mutation in a melanoma risk gene. Many of the mutations detected were in the MITF gene (E318K variant), and the overall prevalence of gene mutations was over 2.5%. …
Tag: Cancer Research
Permanent link to this article: https://inheritedcancer.net/nlf20265/
ICARE Newsletter Fall 2026
Ovarian Cancer Survivors
ICARE Newsletter Fall 2026
Ovarian Cancer Survivors
A new study shows that women with high grade serous ovarian cancer who remain cancer free for 7 years or more had nearly the same mortality risk as the general U.S. population. Of note, most of the women in this study had stage 3 ovarian cancer. Those with homologous repair deficiency (HRD) ovarian tumors (which …
Permanent link to this article: https://inheritedcancer.net/nlf20266/
ICARE Newsletter Fall 2026
NHS Galleri Trial: Blood Test for Cancer Detection
ICARE Newsletter Fall 2026
NHS Galleri Trial: Blood Test for Cancer Detection
A new study (NHS-Galleri trial) tested whether a simple blood test could catch more cancers early. Bottom line: Stage 3 and 4 cancers (together) were not lowered by this study, so this test is NOT ready for prime time yet! A small silver lining is that when looking at stage 4 cancers alone, there was …
Permanent link to this article: https://inheritedcancer.net/nlf20269/
ICARE Newsletter Fall 2026
BRCA1: Hormone Replacement Therapy After Ovary Removal
ICARE Newsletter Fall 2026
BRCA1: Hormone Replacement Therapy After Ovary Removal
A new study shows that estrogen-only hormone replacement therapy (HRT) after ovary removal can LOWER breast cancer risk in cancer-free women carrying the BRCA1 genetic mutation. This study showed that women using HRT had many fewer cases of breast cancer compared to those that did not use HRT (11% vs 19%). The longer women used …
Permanent link to this article: https://inheritedcancer.net/nlf20268/
ICARE Social Media Post May 2025
BRIP1: Third Most Common Gene for Inherited Ovarian Cancer
ICARE Social Media Post May 2025
BRIP1: Third Most Common Gene for Inherited Ovarian Cancer
A new study suggests that BRIP1 might be the THIRD most common gene for inherited ovarian cancer. BRCA1/2 mutations were found in almost 15%, while the frequency of mutations in other homologous recombination repair (HRR) genes among unselected ovarian cancer patients was: Why is this important?Testing in patients with ovarian cancer through inherited cancer multi-gene …
Permanent link to this article: https://inheritedcancer.net/post52325/
ICARE Social Media Post May 2025
Inherited Prostate Cancer: PARP Inhibitors
ICARE Social Media Post May 2025
Inherited Prostate Cancer: PARP Inhibitors
A new meta-analysis study looking at prior studies of PARP inhibitors in patients with metastatic castration-resistant prostate cancer and an inherited gene mutation showed: Learn more at: https://pubmed.ncbi.nlm.nih.gov/39848867/ Reference: Naqvi, et al. Eur Urol. 2025:S0302-2838(24)02760-X. PMID: 39848867.
Permanent link to this article: https://inheritedcancer.net/post52125/



